TrialBMC gastroenterology2014

Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients.

Nikolai V Kuznetsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.